Grassley says FDA was aware of Avandia danger

05/25/2007 | Washington Post (tiered subscription model), The

Sen. Charles Grassley, R-Iowa, said the FDA's own preliminary evaluation indicated significant heart risk from the GlaxoSmithKline diabetes drug Avandia. Grassley also noted FDA safety watchdogs urged a black-box warning for the drug several months ago, and he criticized the FDA for wanting to wait up to two years for data from a new clinical trial.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ